Reduction of oxalate-induced renal tubular epithelial (NRK-52E) cell injury and inhibition of calcium oxalate crystallisation in vitro by aqueous extract of Achyranthes aspera

Anshu Aggarwal, Simran Tandon, Surinder K. Singla, Chanderdeep Tandon

Abstract


Despite considerable progress in medical therapy, there is no satisfactory drug to treat kidney stones. Therefore, this study is aimed to look for an alternative treatment by using Achyranthes aspera. Here, the inhibitory potency of A. aspera was investigated on nucleation and the growth of the calcium oxalate (CaOx) crystals as well as on oxalate-induced cell injury of NRK 52E renal epithelial cells in vitro. Data are expressed as mean values of three independent experiments (each in triplicate) and analysed by the analysis of variance (P <0.05) to estimate the differences between values of extracts tested. A. aspera extract exhibited a concentration-dependent inhibition of the growth of CaOx crystals but a similar pattern of inhibition was not observed with increase in the plant extract concentration for the nucleation assay. When NRK 52E cells were injured by exposure to oxalate for 72 hours, A. aspera extract prevented the injury
in a dose-dependent manner. On treatment with the different concentrations of the plant, the cell viability increased and the lactate dehydrogenase (LDH) release decreased in a concentration-dependent manner. These studies indicate that A. aspera extract besides having a cytoprotective role also has a potential to inhibit both nucleation and the growth of the CaOx crystals and can prove to be a potent candidate for phytotherapy against urolithiasis.
Key words: Achyranthes aspera, calcium oxalate, NRK 52E, phytotherapy, urolithiasis

Full Text:

PDF

References


Kumar V, Farell G, Deganello S, Lieske JC. Annexin II is present

on renal epithelial cells and binds calcium oxalate monohydrate

crystals. J Am Soc Nephrol 2003;14:289-97.

Prasad KV, Sujatha D, Bharathi K. Herbal drugs in urolithiasis: A

review. Phycog Rev 2007;1:175-9.

Schroder FH, Verkoelen CF, Romijn JC, DeBruijn WC, Boeve ER,

Cao L. Association of calcium oxalate monohydrate crystals with

MDCK cells. Kidney Int 1995;48:129-38.

Verkoelen CF, Verhulst A. Proposed mechanisms in renal tubular

crystal retention. Kidney Int 2007;72:13-8.

Khan SR. CaOx crystal interaction with renal epithelium,

mechanism of crystal adhesion and its impact on stone

development. Urol Res 1995;23:71-9.

Maroni PD, Koul S, Chandhoke PS, Meacham RB, Koul HK.

Oxalate toxicity in cultured mouse inner medullary collecting

duct cells. J Urol 2005;174:757-60.

Jonassen JA, Kohjimoto Y, Scheid CR, Schmidt M. Oxalate toxicity

in renal cells. Urol Res 2005;33:329-39.

Kok DJ, Khan SR. Calcium oxalate nephrolithiasis, a free or fixed

particle disease. Kidney Int 1994;46:847-54.

Menon M, Koul H. Calcium oxalate nephrolithiasis. J Clin

Endocrinol Metab 1992;74:703-7.

Jethi RK, Duggal B, Sahota RS, Gupta M, Sofat IB. Effect of the

aqueous extract of an ayurvedic compound preparation on

mineralization and demineralization reactions. Indian J Med Res

;78:422-5.

Barros ME, Schor N, Boim MA. Effect of an aqueous extract from

P. niruri on calcium oxalate crystallization in vitro. Urol Res

;30:374-9.

Service RF. Infections diseases: Antibiotics that resist resistance.

Science 1995;70:724-7.

Pakrashi A, Bhattacharya N. Abortifacient principle of Achyranthes

aspera Linn. Indian J Exp Biol 1977;15:856-8.

Kamboj VP, Dhawan BN. Research on plants for fertility regulation

in India. J Ethnopharmacol 1982;6:191-226.

Misra TN, Singh RS, Pandey HS, Prasad C, Singh BP. Antifungal

essential oils and a long chain alcohol from Achyranthes aspera.

Phytochemistry 1992;31:1811-2.

Gokhale AB, Damre AS, Kulkarni KR, Saraf MN. Preliminary

evaluation of anti-inflammatory and anti-arthritic activity of S.

lappa, A. speciosa and A. aspera. Phytomedicine 2002;9:433-7.

Rao V, Duddukuri GR, Babu G, Rao R. Immunomodulatory activity

of Achyranthes aspera on the elicitation of antigen-specific murine

antibody response. Pharm Biol 2002;40:175-8.

Chakrabarti R, Vasudeva RY. Achyranthes aspera stimulates the

immunity and enhances the antigen clearance in Catla catla. Int

Immunopharmacol 2006;6:782-90.

Kandil O, Radwan NM, Hassan AB, Amer AM, El-Banna HA.

Extracts and fractions of Thymus capitatus exhibit antimicrobial

activities. J Ethnopharmacol 1994;44:19-24.

Moriyama MT, Miyazawa K, Noda K, Oka M, Tanaka M, Suzuki K.

Reduction in oxalate-induced renal tubular epithelial cell injury

by an extract from Quercus salicina Blume/Quercus stenophylla

Makino. Urol Res 2007;35:295-300.

Hennequin C, Lalanne V, Daudon M, Lacour B, Drueke T. A new

approach to studying inhibitors of calcium oxalate crystal growth.

Urol Res 1993;21:101-8.

Nakagawa Y, Abram V, Parks JH, Lau HS, Kawooya JK, Coe FL.

Urine glycoprotein crystal growth inhibitors. Evidence for a

molecular abnormality in calcium oxalate nephrolithiasis. J Clin

Invest 1985;76:1455-62.

Jeong B, Kwak C, Cho KS, Kim BS, Hong SK, Kim J, et al. Apoptosis

induced by oxalate in human renal tubular epithelial HK-2 cells.

Urol Res 2005;33:87-92.

Wagner A, Marc A, Engasser JM. The use of lactate dehydrogenase

(LDH) release kinetics for the evaluation of death and growth

of mammalian cells in perfusion reactors. Biotechnol Bioeng

;39:320-6.

Goyal BR, Goyal RK, Mehta AA. Phyto-pharmacology of

Achyranthes aspera: A review. Pharmacognosy Rev 2007;1:143-50.

Beghalia M, Ghalem S, Allali H, Belouatek A, Marouf A. Inhibition

of calcium oxalate monohydrate crystal growth using Algerian

medicinal plants. J Med Plants Res 2008;2:66-70.

Wesson JA, Worcester EM, Wiessner JH, Mandel NS, Kleinman JG.

Control of calcium oxalate structure and cell adherence by urinary

macromolecules. Kidney Int 1998;53:952-7.

Gupta SS, Verma SC, Ram AK, Tripathi RM. Diuretic effect of the

saponin of Achyranthes aspera (apamarga). Indian J Pharmacol

;4:208-21.

Atmani F, Farell G, Lieske JC. Extract from Herniaria hirsuta coats

calcium oxalate monohydrate crystals and blocks their adhesion

to renal epithelial cells. J Urol 2004;172:1510-4.

Campos AH, Schor N. Phyllanthus niruri inhibits calcium oxalate

endocytosis by renal tubular cells: Its role in urolithiasis. Nephron

;81:393-7.

Bashir S, Gilani AH. Antiurolithic effect of Bergenia ligulata

rhizome: An explanation of the underlying mechanisms. J

Ethnopharmacol 2009;122:106-16.

Bijarnia RK, Kaur T, Singla SK, Tandon C. A novel calcium oxalate

crystal growth inhibitory protein from the seeds of Dolichos

biflorus (L.). Protein J 2009;28:161-8.

Kaur T, Bijarnia RK, Singla SK, Tandon C. Purification and

characterization of an anticalcifying protein from the seeds of

Trachyspermum ammi (L.). Protein Pept Lett 2009;16:173-81.




DOI: http://dx.doi.org/10.22377/ijgp.v4i3.138

Refbacks

  • There are currently no refbacks.